These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 4744014)

  • 1. Clinical symposium on cefazolin.
    J Infect Dis; 1973 Oct; 128():Suppl:S307-4. PubMed ID: 4744014
    [No Abstract]   [Full Text] [Related]  

  • 2. Summary of symposium on cefazolin.
    Kaye D
    J Infect Dis; 1973 Oct; 128():Suppl:S422-4. PubMed ID: 4744025
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Coagulopathy with cefazolin in uremia.
    Lerner PI; Lubin A
    N Engl J Med; 1974 Jun; 290(23):1324. PubMed ID: 4827633
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Reduced particulate matter in lyophilized Kefzol.
    Turco SJ; Davis NM; Bhatia R
    Am J Hosp Pharm; 1974 Aug; 31(8):722-3. PubMed ID: 4852913
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Particulate matter in Ancef and Kefzol.
    Turco SJ; Davis NM; Bhatia R
    Am J Hosp Pharm; 1974 Mar; 31(3):222 passim. PubMed ID: 4819435
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodialysis of cefazolin.
    McCloskey RV; Forland MF; Sweeney MJ; Lawrence DN
    J Infect Dis; 1973 Oct; 128():Suppl:S358-6. PubMed ID: 4744018
    [No Abstract]   [Full Text] [Related]  

  • 7. Levels of cefazolin in human bile.
    Ram MD; Watanatittan S
    J Infect Dis; 1973 Oct; 128():Suppl:S361-3. PubMed ID: 4744019
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of oral cefazolin for infantile bacterial dysentery].
    Sato H; Watanabe O; Niino K; Nakazawa S; Yamaguchi T
    Jpn J Antibiot; 1973 Apr; 26(2):104-8. PubMed ID: 4542535
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacology of cefazolin in patients with normal and abnormal renal function.
    Levison ME; Levison SP; Ries K; Kaye D
    J Infect Dis; 1973 Oct; 128():Suppl:S354-7. PubMed ID: 4744017
    [No Abstract]   [Full Text] [Related]  

  • 10. Semiautomated turbidimetric microbiological assay for determination of cefazolin.
    Pitkin D; Actor P; Holl W; Post A; Weisbach JA
    Antimicrob Agents Chemother; 1974 Mar; 5(3):223-7. PubMed ID: 4209068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antistaphylococcic effect of cephalothin, cephaloridine and cephazoline. I. In vitro activity].
    Martinetto P; Savoia D; Cavallo G
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):374-6. PubMed ID: 5155946
    [No Abstract]   [Full Text] [Related]  

  • 12. Five cephalosporins: pharmacokinetics and their relation to antibacterial potency.
    Sohn C; Pitkin D; Grappel S; Zajac I; Actor P; Alexander F; Lentnek A; Wikler M; Stote R; Dubb J
    Clin Ther; 1984; 6(4):560-70. PubMed ID: 6467282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost containment through restriction of cephalosporins.
    Britton HL; Schwinghammer TL; Romano MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimycotic effect of diaryl sulfides with open chains and ring systems containing pyridine and thiadiazole units].
    Bottino F; Russo F; Blandino G
    Farmaco Sci; 1982 May; 37(5):298-303. PubMed ID: 7095142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cefamandole and cefazolin during cardiopulmonary bypass.
    Bryan CS; Smith CW; Sutton JP; Allen WB; Blanding R; Gangemi JD
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):222-5. PubMed ID: 6348425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility to cefazolin, cefamandole and ceftazidime in Staphylococcus strains].
    Wiktorowicz-Belzyt E; Wojak I; Janicka G
    Med Dosw Mikrobiol; 1997; 49(1-2):35-43. PubMed ID: 9411070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symposium on antimicrobial therapy. IV. The cephalosporins.
    Greenfield RA
    J Okla State Med Assoc; 1993 Jan; 86(1):7-12. PubMed ID: 8426246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory concentrations of cefoperazone, cefazolin, cefamandole, cephaloridine, and cefoxitin for 300 gram-negative clinical isolates.
    Trabulsi LR; Pereira da Silva Almada N; Marques LR
    Clin Ther; 1980; 3(Spec Issue):145-8. PubMed ID: 6446390
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute bacterial peritonitis: permeability of cephalosporins in the peritoneal cavity.
    Eyal A; Greif F; Shalit I; Lelcuk S
    Isr J Med Sci; 1996 Dec; 32(12):1317-9. PubMed ID: 9007180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cefazolin microspheres to treat localized methicillin-resistant Staphylococcus aureus infections in rats.
    Fallon MT; Shafer W; Jacob E
    J Surg Res; 1999 Sep; 86(1):97-102. PubMed ID: 10452874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.